Makiko Takeichi

568 total citations
12 papers, 423 citations indexed

About

Makiko Takeichi is a scholar working on Cardiology and Cardiovascular Medicine, Small Animals and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Makiko Takeichi has authored 12 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 2 papers in Small Animals and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Makiko Takeichi's work include Atrial Fibrillation Management and Outcomes (6 papers), Cardiac Arrhythmias and Treatments (4 papers) and Infectious Diseases and Mycology (2 papers). Makiko Takeichi is often cited by papers focused on Atrial Fibrillation Management and Outcomes (6 papers), Cardiac Arrhythmias and Treatments (4 papers) and Infectious Diseases and Mycology (2 papers). Makiko Takeichi collaborates with scholars based in Japan, Germany and Switzerland. Makiko Takeichi's co-authors include Ayumi Kitano, Daisuke Nakada, Hideyuki Oguro, George Wendt, Yusuke Saitoh, N. D. Ryan, Sean J. Morrison, Boaz P. Levi, Kevin A. Hoegenauer and Yu-Jung Tseng and has published in prestigious journals such as Nature, Circulation and Scientific Reports.

In The Last Decade

Makiko Takeichi

10 papers receiving 420 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Makiko Takeichi Japan	5	150	135	105	60	55	12	423
Simona Vaccargiu Italy	10	47 0.3×	53 0.4×	90 0.9×	43 0.7×	34 0.6×	17	467
Sarah K. Westbury United Kingdom	11	205 1.4×	28 0.2×	75 0.7×	48 0.8×	75 1.4×	27	380
Yukiko Nakayama Japan	6	163 1.1×	35 0.3×	165 1.6×	35 0.6×	43 0.8×	9	451
Latasha Abeynaike Australia	8	63 0.4×	177 1.3×	76 0.7×	25 0.4×	26 0.5×	10	361
Xavier Muñoz Spain	11	61 0.4×	146 1.1×	139 1.3×	18 0.3×	25 0.5×	16	393
Soumitra Tole Canada	9	50 0.3×	65 0.5×	104 1.0×	21 0.3×	33 0.6×	20	339
Heidi A. Trau United States	9	76 0.5×	45 0.3×	119 1.1×	12 0.2×	105 1.9×	12	340
Vicky Chaar France	10	146 1.0×	42 0.3×	163 1.6×	38 0.6×	210 3.8×	10	548
Ye Jee Shim South Korea	9	88 0.6×	40 0.3×	144 1.4×	10 0.2×	42 0.8×	49	422
Vincenzo Leo United Kingdom	8	174 1.2×	28 0.2×	116 1.1×	131 2.2×	59 1.1×	10	366

Countries citing papers authored by Makiko Takeichi

Since Specialization

Citations

This map shows the geographic impact of Makiko Takeichi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Makiko Takeichi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Makiko Takeichi more than expected).

Fields of papers citing papers by Makiko Takeichi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Makiko Takeichi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Makiko Takeichi. The network helps show where Makiko Takeichi may publish in the future.

Co-authorship network of co-authors of Makiko Takeichi

This figure shows the co-authorship network connecting the top 25 collaborators of Makiko Takeichi. A scholar is included among the top collaborators of Makiko Takeichi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Makiko Takeichi. Makiko Takeichi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Takeichi, Makiko, et al.. (2025). Utility of sputum specimen quality evaluation in improving diagnostic accuracy for Nontuberculous mycobacterium pulmonary disease. Journal of Infection and Chemotherapy. 31(9). 102784–102784.

Okami, Suguru, Christoph Ohlmeier, Makiko Takeichi, et al.. (2024). Vericiguat Use in Patients with Heart Failure in Real-World Settings during the First Year after the Drug Authorization in Japan. Journal of Clinical Medicine. 13(11). 3222–3222. 4 indexed citations

Sakamoto, Susumu, et al.. (2024). Usefulness of bronchial sputum aspirate specimens for the diagnosis of Non-tuberculous mycobacterial pulmonary disease. Respiratory Investigation. 63(1). 174–179.

Okami, Suguru, M. Cecilia Aguila, Zuzana Mohrová, et al.. (2024). Initiation and continuation of pharmacological therapies in patients hospitalized for heart failure in Japan. Scientific Reports. 14(1). 2 indexed citations

Miyamoto, Susumu, Takanori Ikeda, Satoshi Ogawa, et al.. (2020). Clinical Risk Factors of Thromboembolic and Major Bleeding Events for Patients with Atrial Fibrillation Treated with Rivaroxaban in Japan. Journal of Stroke and Cerebrovascular Diseases. 29(4). 104584–104584. 8 indexed citations

Nakagawara, Jyoji, Takanori Ikeda, Satoshi Ogawa, et al.. (2019). Real-world outcomes of rivaroxaban treatment in patients with nonvalvular atrial fibrillation and worsening renal function. Journal of Cardiology. 74(6). 501–506. 1 indexed citations

Ikeda, Takanori, Satoshi Ogawa, Takanari Kitazono, et al.. (2019). Real-world outcomes of the Xarelto Post-Authorization Safety & Effectiveness Study in Japanese Patients with Atrial Fibrillation (XAPASS). Journal of Cardiology. 74(1). 60–66. 26 indexed citations

Minematsu, Kazuo, Takanori Ikeda, Satoshi Ogawa, et al.. (2019). Real-World Outcomes of Rivaroxaban Treatment in Patients with Both Nonvalvular Atrial Fibrillation and a History of Ischemic Stroke/Transient Ischemic Attack. Cerebrovascular Diseases. 48(1-2). 53–60. 4 indexed citations

Ikeda, Takanori, Satoshi Ogawa, Takanari Kitazono, et al.. (2018). Abstract 10999: Outcomes Associated With Under-Dosing of Rivaroxaban for Management of Non-Valvular Atrial Fibrillation in Real World Clinical Setting From the XAPASS (Xarelto Post-Authorization Safety and Effectiveness Study in Japanese Patients With Atrial Fibrillation). Circulation. 1 indexed citations

10.

Ogawa, Satoshi, Kazuo Minematsu, Takanori Ikeda, et al.. (2018). Design and baseline characteristics of the Xarelto Post‐Authorization Safety & Effectiveness Study in Japanese Patients with Atrial Fibrillation (XAPASS). Journal of Arrhythmia. 34(2). 167–175. 16 indexed citations

11.

Chapple, Richard H., Yu-Jung Tseng, Tianyuan Hu, et al.. (2018). Lineage tracing of murine adult hematopoietic stem cells reveals active contribution to steady-state hematopoiesis. Blood Advances. 2(11). 1220–1228. 62 indexed citations

12.

Nakada, Daisuke, Hideyuki Oguro, Boaz P. Levi, et al.. (2014). Oestrogen increases haematopoietic stem-cell self-renewal in females and during pregnancy. Nature. 505(7484). 555–558. 299 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact